Sotera Health Reports First-Quarter 2024 Results

Go back to Sotera Health Reports First-Quarter 2024 Results

Sotera Health (SHC) PT Lowered to $17 at RBC Capital

May 3, 2024 6:48 AM EDT

RBC Capital analyst Sean Dodge lowered the price target on Sotera Health (NASDAQ: SHC) to $17.00 (from $20.00) while maintaining a Outperform rating.

The analyst comments "1Q24 results were mixed with revenue 1.5% above consensus and EBITDA 3.8% below on higher-than-expected COGS and SG&A. Along... More